IPO Announced

SpyGlass Pharma IPO

US$150m raised

Lodged 5 Feb 2026 · NASDAQ: SGP · US$16.00 per share

Advisers

SpyGlass Pharma

Issuer

Not disclosed

Issuer
SpyGlass Pharma
Issuer based in
United States
Sector
Ophthalmology
Tags
Ophthalmology, Pharma

Similar deals

All ophthalmology deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.